BF Biosciences limited is a joint venture between Ferozsons Laboratories Limited of Pakistan and Bagó Group of Argentina.rnThe Bagó group was established in 1934, and since 78 years is the leading pharmaceutical group in Latin America.rnIn 2002, Ferozsons and Bagó entered into commercial partnership to launch the Bago range of quality branded generics in the field of oncology and Hepatology in Pakistan. Within the first two years, together we achieved a leadership position, becoming one of the top 3 companies in both Oncology and Hepatology segments.rnIn December 2004, Bagó and Ferozsons signed an agreement to form BF Biosciences Limited, Pakistan’s first biotech formulation company. The Plant, which has been built on a 27 acre site in Lahore, Pakistan, is manufacturing biogeneric medicines for the local and export markets.rnThe manufacturing facility has a covered area of 9,000 m2, and has been designed and installed by Telstar Projects, one of Europe’s leading pharmaceutical design and engineering companies, in compliance with EU and USFDA requirements.rnCurrently BF Biosciences in Market Leader in the field of Hepatology offering a vast range of products for treating Hepatitis B & C and managing the complications of Liver Cirrhosis. Our Major brands are as follows:rn• PegINF (Peginterferon alfa 2-a)rn• Centaurus (entecavir)rn• Novapressin (Terlipressin)rn• Rifaxa (Rifaximin)rn• INF (Interferon alfa 2-b)